Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity (Tables)

v3.25.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2025
Stockholders' Equity  
Schedule of Stock-Based Compensation Expense

Three Months Ended March 31, 

($ in thousands)

2025

    

2024

Fortress:

Employee and non-employee awards

$

2,607

$

2,193

Executive awards

 

180

 

224

Partner Companies:

Avenue

 

185

 

191

Checkpoint

 

1,956

 

709

Mustang

 

38

 

77

Journey

1,323

1,406

Other

 

 

57

Total stock-based compensation expense

$

6,289

$

4,857

Schedule of Stock Option Activities

Weighted average

Total

remaining

Weighted average

weighted average

contractual life

    

Number of shares

    

exercise price

    

intrinsic value

    

(years)

Options vested and expected to vest at December 31, 2024

 

558,896

$

2.32

$

186,300

 

6.02

Forfeited

(540,000)

1.68

Options vested and expected to vest at March 31, 2025

 

18,896

$

20.55

$

 

0.52

Options vested and exercisable at March 31, 2025

18,896

$

20.55

$

 

0.52

Schedule of Restricted Stock Awards and Restricted Stock Units

    

    

Weighted

average grant

Number of shares

price

Unvested balance at December 31, 2024

4,414,724

$

12.87

Restricted stock granted

1,204,360

2.03

Restricted stock vested

(11,331)

34.12

Restricted stock units vested

(77,124)

29.17

Unvested balance at March 31, 2025

5,530,629

$

10.24

Schedule of Warrant activities

Total weighted

Weighted average

average

remaining

Number of

Weighted average

 intrinsic

contractual life

    

shares

    

exercise price

    

value

    

(years)

Outstanding as of December 31, 2024

 

14,406,201

$

2.15

$

2,933,774

 

4.46

Exercised

(10,000)

1.68

Outstanding as of March 31, 2025

 

14,396,201

$

2.16

$

 

4.22

Exercisable as of March 31, 2025

 

14,396,201

$

2.16

$

 

4.22